Human Phenotype Ontology 
Grandparent Node:
expand
Neoplasm (HP:0002664)help
Parent Node:
expand
Abnormal adipose tissue morphology (HP:0009124)help
Parent Node:
expand
Neoplasm by anatomical site (HP:0011793)help
..Starting node
..expand
Neoplasm of fatty tissue (HP:0200013)help
Term ID: 200013
Name: Neoplasm of fatty tissue
Synonym: Tumor of fatty tissue; Tumour of fatty tissue
Definition: A tumor (abnormal growth of tissue) of adipose tissue.
Comments:
Reference: HP:0200013
Genes and Diseases:
 
       Child Nodes:
........expandLipomatous tumor (HP:0012031) help
................... HP:0001012 Multiple lipomas
................... HP:0012032 Lipoma
................... HP:0012034 Liposarcoma

 Sister Nodes: 
..expandHematological neoplasm (HP:0004377) help
..expandMalignant mesothelioma (HP:0100001) help
..expandNeoplasm of head and neck (HP:0012288) help
..expandNeoplasm of striated muscle (HP:0009728) help
..expandNeoplasm of the breast (HP:0100013) help
..expandNeoplasm of the ear (HP:0012780) help
..expandNeoplasm of the endocrine system (HP:0100568) help
..expandNeoplasm of the eye (HP:0100012) help
..expandNeoplasm of the gastrointestinal tract (HP:0007378) help
..expandNeoplasm of the genitourinary tract (HP:0007379) help
..expandNeoplasm of the heart (HP:0100544) help
..expandNeoplasm of the lip (HP:0100604) help
..expandNeoplasm of the nail (HP:0100826) help
..expandNeoplasm of the nervous system (HP:0004375) help
..expandNeoplasm of the oral cavity (HP:0100649) help
..expandNeoplasm of the pancreas (HP:0002894) help
..expandNeoplasm of the respiratory system (HP:0100606) help
..expandNeoplasm of the skeletal system (HP:0010622) help
..expandNeoplasm of the skin (HP:0008069) help
..expandNeoplasm of the thymus (HP:0100521) help
..expandRetroperitoneal chemodectomas (HP:0006729) help
..expandSoft tissue neoplasm (HP:0031459) help
..expandVascular neoplasm (HP:0100742) help
InputHPO IDHPO termDistanceGeneGene id entrezHGNC IDDiseaseIdDiseaseNameFrequencyOnsetHGMD variantsClinVar variants
 
HPO disease - gene - phenotype typical associations:
 
HPO disease - gene - phenotype less frequent non-typical associations:
HP:0200013HP:0200013Neoplasm of fatty tissue0ABCC6 CL E G H36857ORPHA:758Pseudoxanthoma elasticum415
HP:0200013HP:0200013Neoplasm of fatty tissue0AKT1 CL E G H207391ORPHA:201Cowden syndrome54
HP:0200013HP:0200013Neoplasm of fatty tissue0AKT1 CL E G H207391OMIM:615109Cowden syndrome 654
HP:0200013HP:0200013Neoplasm of fatty tissue0AKT1 CL E G H207391ORPHA:744Proteus syndrome54
HP:0200013HP:0200013Neoplasm of fatty tissue0AKT1 CL E G H207391OMIM:176920Proteus syndrome, somatic54
HP:0200013HP:0200013Neoplasm of fatty tissue0ALX1 CL E G H80921494ORPHA:306542Frontonasal dysplasia-severe microphthalmia-severe facial clefting syndrome5
HP:0200013HP:0200013Neoplasm of fatty tissue0ALX3 CL E G H257449OMIM:136760Frontonasal dysplasia 19
HP:0200013HP:0200013Neoplasm of fatty tissue0ALX3 CL E G H257449ORPHA:391474Frontorhiny9
HP:0200013HP:0200013Neoplasm of fatty tissue0AP2S1 CL E G H1175565OMIM:600740Hypocalciuric hypercalcemia, familial, type III6
HP:0200013HP:0200013Neoplasm of fatty tissue0APC CL E G H324583OMIM:175100Adenomatous polyposis coli3179
HP:0200013HP:0200013Neoplasm of fatty tissue0APC CL E G H324583ORPHA:247806APC-related attenuated familial adenomatous polyposis3179
HP:0200013HP:0200013Neoplasm of fatty tissue0APC CL E G H324583ORPHA:79665Gardner syndrome3179
HP:0200013HP:0200013Neoplasm of fatty tissue0BMPR1A CL E G H6571076ORPHA:79076Juvenile polyposis of infancy385
HP:0200013HP:0200013Neoplasm of fatty tissue0CCL2 CL E G H634710618OMIM:182940Neural tube defects, susceptibility to3
HP:0200013HP:0200013Neoplasm of fatty tissue0CDC73 CL E G H7957716783ORPHA:99880Hyperparathyroidism-jaw tumor syndrome169
HP:0200013HP:0200013Neoplasm of fatty tissue0CDC73 CL E G H7957716783ORPHA:143Parathyroid carcinoma169
HP:0200013HP:0200013Neoplasm of fatty tissue0CDKN1A CL E G H10261784ORPHA:652Multiple endocrine neoplasia type 12
HP:0200013HP:0200013Neoplasm of fatty tissue0CDKN1B CL E G H10271785ORPHA:652Multiple endocrine neoplasia type 1102
HP:0200013HP:0200013Neoplasm of fatty tissue0CDKN1B CL E G H10271785ORPHA:276152Multiple endocrine neoplasia type 4102
HP:0200013HP:0200013Neoplasm of fatty tissue0CDKN2B CL E G H10301788ORPHA:652Multiple endocrine neoplasia type 11
HP:0200013HP:0200013Neoplasm of fatty tissue0CDKN2C CL E G H10311789ORPHA:652Multiple endocrine neoplasia type 1
HP:0200013HP:0200013Neoplasm of fatty tissue0ENPP1 CL E G H51673356ORPHA:758Pseudoxanthoma elasticum151
HP:0200013HP:0200013Neoplasm of fatty tissue0FGFR1 CL E G H22603688ORPHA:2396Encephalocraniocutaneous lipomatosis172
HP:0200013HP:0200013Neoplasm of fatty tissue0FGFR1 CL E G H22603688OMIM:613001Encephalocraniocutaneous lipomatosis172
HP:0200013HP:0200013Neoplasm of fatty tissue0FLCN CL E G H20116327310ORPHA:122Birt-Hogg-Dubé syndrome332
HP:0200013HP:0200013Neoplasm of fatty tissue0FLCN CL E G H20116327310OMIM:135150Birt-Hogg-Dube syndrome332
HP:0200013HP:0200013Neoplasm of fatty tissue0FUZ CL E G H8019926219OMIM:182940Neural tube defects, susceptibility to3
HP:0200013HP:0200013Neoplasm of fatty tissue0GNA11 CL E G H27674379OMIM:145981Hypocalciuric hypercalcemia, familial, type II16
HP:0200013HP:0200013Neoplasm of fatty tissue0KLLN CL E G H10014474837212ORPHA:201Cowden syndrome1
HP:0200013HP:0200013Neoplasm of fatty tissue0KRAS CL E G H38456407ORPHA:2396Encephalocraniocutaneous lipomatosis196
HP:0200013HP:0200013Neoplasm of fatty tissue0LEMD3 CL E G H2359228887ORPHA:1879Melorheostosis with osteopoikilosis68
HP:0200013HP:0200013Neoplasm of fatty tissue0MEN1 CL E G H42217010OMIM:131100Multiple endocrine neoplasia 1462
HP:0200013HP:0200013Neoplasm of fatty tissue0MEN1 CL E G H42217010ORPHA:652Multiple endocrine neoplasia type 1462
HP:0200013HP:0200013Neoplasm of fatty tissue0MFN2 CL E G H992716877ORPHA:2398Multiple symmetric lipomatosis203
HP:0200013HP:0200013Neoplasm of fatty tissue0MSTO1 CL E G H5515429678ORPHA:502423Mitochondrial myopathy-cerebellar ataxia-pigmentary retinopathy syndrome
HP:0200013HP:0200013Neoplasm of fatty tissue0MSTO1 CL E G H5515429678OMIM:617675Myopathy, mitochondrial, and ataxia
HP:0200013HP:0200013Neoplasm of fatty tissue0ND5 CL E G H45407461ORPHA:551MERRF
HP:0200013HP:0200013Neoplasm of fatty tissue0PIK3CA CL E G H52908975OMIM:612918Congenital lipomatous overgrowth, vascular malformations, and epidermal nevi162
HP:0200013HP:0200013Neoplasm of fatty tissue0PIK3CA CL E G H52908975ORPHA:201Cowden syndrome162
HP:0200013HP:0200013Neoplasm of fatty tissue0PIK3CA CL E G H52908975OMIM:615108Cowden syndrome 5162
HP:0200013HP:0200013Neoplasm of fatty tissue0PIK3CA CL E G H52908975ORPHA:276280Hemihyperplasia-multiple lipomatosis syndrome162
HP:0200013HP:0200013Neoplasm of fatty tissue0PTEN CL E G H57289588ORPHA:109Bannayan-Riley-Ruvalcaba syndrome948
HP:0200013HP:0200013Neoplasm of fatty tissue0PTEN CL E G H57289588ORPHA:201Cowden syndrome948
HP:0200013HP:0200013Neoplasm of fatty tissue0PTEN CL E G H57289588OMIM:158350Cowden syndrome 1948
HP:0200013HP:0200013Neoplasm of fatty tissue0PTEN CL E G H57289588ORPHA:79076Juvenile polyposis of infancy948
HP:0200013HP:0200013Neoplasm of fatty tissue0PTEN CL E G H57289588ORPHA:744Proteus syndrome948
HP:0200013HP:0200013Neoplasm of fatty tissue0PTEN CL E G H57289588ORPHA:2969Proteus-like syndrome948
HP:0200013HP:0200013Neoplasm of fatty tissue0RNR1 CL E G H45497470ORPHA:551MERRF
HP:0200013HP:0200013Neoplasm of fatty tissue0RPL10 CL E G H613410298ORPHA:459070X-linked intellectual disability-cerebellar hypoplasia-spondylo-epiphyseal dysplasia syndrome10
HP:0200013HP:0200013Neoplasm of fatty tissue0RPL10 CL E G H613410298ORPHA:435938X-linked microcephaly-growth retardation-prognathism-cryptorchidism syndrome10
HP:0200013HP:0200013Neoplasm of fatty tissue0SDHB CL E G H639010681ORPHA:201Cowden syndrome237
HP:0200013HP:0200013Neoplasm of fatty tissue0SDHC CL E G H639110682ORPHA:201Cowden syndrome147
HP:0200013HP:0200013Neoplasm of fatty tissue0SDHD CL E G H639210683ORPHA:201Cowden syndrome129
HP:0200013HP:0200013Neoplasm of fatty tissue0SEC23B CL E G H1048310702ORPHA:201Cowden syndrome60
HP:0200013HP:0200013Neoplasm of fatty tissue0SPRED1 CL E G H16174220249OMIM:611431Legius syndrome136
HP:0200013HP:0200013Neoplasm of fatty tissue0SPRED1 CL E G H16174220249ORPHA:137605Legius syndrome136
HP:0200013HP:0200013Neoplasm of fatty tissue0TAF1 CL E G H687211535ORPHA:480907X-linked intellectual disability-global development delay-facial dysmorphism-sacral caudal remnant syndrome21
HP:0200013HP:0200013Neoplasm of fatty tissue0TBXT CL E G H686211515OMIM:182940Neural tube defects, susceptibility to
HP:0200013HP:0200013Neoplasm of fatty tissue0TRNF CL E G H45587481ORPHA:551MERRF
HP:0200013HP:0200013Neoplasm of fatty tissue0TRNH CL E G H45647487ORPHA:551MERRF
HP:0200013HP:0200013Neoplasm of fatty tissue0TRNK CL E G H45667489ORPHA:551MERRF
HP:0200013HP:0200013Neoplasm of fatty tissue0TRNK CL E G H45667489ORPHA:1349Mitochondrial DNA-related cardiomyopathy and hearing loss
HP:0200013HP:0200013Neoplasm of fatty tissue0TRNL1 CL E G H45677490ORPHA:551MERRF
HP:0200013HP:0200013Neoplasm of fatty tissue0TRNP CL E G H45717494ORPHA:551MERRF
HP:0200013HP:0200013Neoplasm of fatty tissue0TRNQ CL E G H45727495ORPHA:551MERRF
HP:0200013HP:0200013Neoplasm of fatty tissue0TRNS1 CL E G H45747497ORPHA:551MERRF
HP:0200013HP:0200013Neoplasm of fatty tissue0TRNS2 CL E G H45757498ORPHA:551MERRF
HP:0200013HP:0200013Neoplasm of fatty tissue0USF3 CL E G H20571730494ORPHA:201Cowden syndrome1
HP:0200013HP:0200013Neoplasm of fatty tissue0VANGL1 CL E G H8183915512OMIM:182940Neural tube defects, susceptibility to111
HP:0200013HP:0200013Neoplasm of fatty tissue0VANGL1 CL E G H8183915512OMIM:600145Sacral defect with anterior meningocele111
HP:0200013HP:0200013Neoplasm of fatty tissue0VANGL2 CL E G H5721615511OMIM:182940Neural tube defects, susceptibility to2
HP:0200013HP:0200013Neoplasm of fatty tissue0ZSWIM6 CL E G H5768829316OMIM:603671Acromelic frontonasal dysostosis5
HP:0200013HP:0200013Neoplasm of fatty tissue0ZSWIM6 CL E G H5768829316ORPHA:1827Acromelic frontonasal dysplasia5
HP:0200013HP:0012031Lipomatous tumor1ABCC6 CL E G H36857ORPHA:758Pseudoxanthoma elasticum415
HP:0200013HP:0012031Lipomatous tumor1AKT1 CL E G H207391ORPHA:201Cowden syndrome54
HP:0200013HP:0012031Lipomatous tumor1AKT1 CL E G H207391OMIM:615109Cowden syndrome 654
HP:0200013HP:0012031Lipomatous tumor1AKT1 CL E G H207391ORPHA:744Proteus syndrome54
HP:0200013HP:0012031Lipomatous tumor1AKT1 CL E G H207391OMIM:176920Proteus syndrome, somatic54
HP:0200013HP:0012031Lipomatous tumor1ALX1 CL E G H80921494ORPHA:306542Frontonasal dysplasia-severe microphthalmia-severe facial clefting syndrome5
HP:0200013HP:0012031Lipomatous tumor1ALX3 CL E G H257449OMIM:136760Frontonasal dysplasia 19
HP:0200013HP:0012031Lipomatous tumor1ALX3 CL E G H257449ORPHA:391474Frontorhiny9
HP:0200013HP:0012031Lipomatous tumor1AP2S1 CL E G H1175565OMIM:600740Hypocalciuric hypercalcemia, familial, type III6
HP:0200013HP:0012031Lipomatous tumor1APC CL E G H324583OMIM:175100Adenomatous polyposis coli3179
HP:0200013HP:0012031Lipomatous tumor1APC CL E G H324583ORPHA:247806APC-related attenuated familial adenomatous polyposis3179
HP:0200013HP:0012031Lipomatous tumor1APC CL E G H324583ORPHA:79665Gardner syndrome3179
HP:0200013HP:0012031Lipomatous tumor1BMPR1A CL E G H6571076ORPHA:79076Juvenile polyposis of infancy385
HP:0200013HP:0012031Lipomatous tumor1CCL2 CL E G H634710618OMIM:182940Neural tube defects, susceptibility to3
HP:0200013HP:0012031Lipomatous tumor1CDC73 CL E G H7957716783ORPHA:99880Hyperparathyroidism-jaw tumor syndrome169
HP:0200013HP:0012031Lipomatous tumor1CDC73 CL E G H7957716783ORPHA:143Parathyroid carcinoma169
HP:0200013HP:0012031Lipomatous tumor1CDKN1A CL E G H10261784ORPHA:652Multiple endocrine neoplasia type 12
HP:0200013HP:0012031Lipomatous tumor1CDKN1B CL E G H10271785ORPHA:652Multiple endocrine neoplasia type 1102
HP:0200013HP:0012031Lipomatous tumor1CDKN1B CL E G H10271785ORPHA:276152Multiple endocrine neoplasia type 4102
HP:0200013HP:0012031Lipomatous tumor1CDKN2B CL E G H10301788ORPHA:652Multiple endocrine neoplasia type 11
HP:0200013HP:0012031Lipomatous tumor1CDKN2C CL E G H10311789ORPHA:652Multiple endocrine neoplasia type 1
HP:0200013HP:0012031Lipomatous tumor1ENPP1 CL E G H51673356ORPHA:758Pseudoxanthoma elasticum151
HP:0200013HP:0012031Lipomatous tumor1FGFR1 CL E G H22603688OMIM:613001Encephalocraniocutaneous lipomatosis172
HP:0200013HP:0012031Lipomatous tumor1FGFR1 CL E G H22603688ORPHA:2396Encephalocraniocutaneous lipomatosis172
HP:0200013HP:0012031Lipomatous tumor1FLCN CL E G H20116327310ORPHA:122Birt-Hogg-Dubé syndrome332
HP:0200013HP:0012031Lipomatous tumor1FLCN CL E G H20116327310OMIM:135150Birt-Hogg-Dube syndrome332
HP:0200013HP:0012031Lipomatous tumor1FUZ CL E G H8019926219OMIM:182940Neural tube defects, susceptibility to3
HP:0200013HP:0012031Lipomatous tumor1GNA11 CL E G H27674379OMIM:145981Hypocalciuric hypercalcemia, familial, type II16
HP:0200013HP:0012031Lipomatous tumor1KLLN CL E G H10014474837212ORPHA:201Cowden syndrome1
HP:0200013HP:0012031Lipomatous tumor1KRAS CL E G H38456407ORPHA:2396Encephalocraniocutaneous lipomatosis196
HP:0200013HP:0012031Lipomatous tumor1LEMD3 CL E G H2359228887ORPHA:1879Melorheostosis with osteopoikilosis68
HP:0200013HP:0012031Lipomatous tumor1MEN1 CL E G H42217010OMIM:131100Multiple endocrine neoplasia 1462
HP:0200013HP:0012031Lipomatous tumor1MEN1 CL E G H42217010ORPHA:652Multiple endocrine neoplasia type 1462
HP:0200013HP:0012031Lipomatous tumor1MFN2 CL E G H992716877ORPHA:2398Multiple symmetric lipomatosis203
HP:0200013HP:0012031Lipomatous tumor1MSTO1 CL E G H5515429678ORPHA:502423Mitochondrial myopathy-cerebellar ataxia-pigmentary retinopathy syndrome
HP:0200013HP:0012031Lipomatous tumor1MSTO1 CL E G H5515429678OMIM:617675Myopathy, mitochondrial, and ataxia
HP:0200013HP:0012031Lipomatous tumor1ND5 CL E G H45407461ORPHA:551MERRF
HP:0200013HP:0012031Lipomatous tumor1PIK3CA CL E G H52908975OMIM:612918Congenital lipomatous overgrowth, vascular malformations, and epidermal nevi162
HP:0200013HP:0012031Lipomatous tumor1PIK3CA CL E G H52908975ORPHA:201Cowden syndrome162
HP:0200013HP:0012031Lipomatous tumor1PIK3CA CL E G H52908975OMIM:615108Cowden syndrome 5162
HP:0200013HP:0012031Lipomatous tumor1PIK3CA CL E G H52908975ORPHA:276280Hemihyperplasia-multiple lipomatosis syndrome162
HP:0200013HP:0012031Lipomatous tumor1PTEN CL E G H57289588ORPHA:109Bannayan-Riley-Ruvalcaba syndrome948
HP:0200013HP:0012031Lipomatous tumor1PTEN CL E G H57289588ORPHA:201Cowden syndrome948
HP:0200013HP:0012031Lipomatous tumor1PTEN CL E G H57289588OMIM:158350Cowden syndrome 1948
HP:0200013HP:0012031Lipomatous tumor1PTEN CL E G H57289588ORPHA:79076Juvenile polyposis of infancy948
HP:0200013HP:0012031Lipomatous tumor1PTEN CL E G H57289588ORPHA:744Proteus syndrome948
HP:0200013HP:0012031Lipomatous tumor1PTEN CL E G H57289588ORPHA:2969Proteus-like syndrome948
HP:0200013HP:0012031Lipomatous tumor1RNR1 CL E G H45497470ORPHA:551MERRF
HP:0200013HP:0012031Lipomatous tumor1RPL10 CL E G H613410298ORPHA:459070X-linked intellectual disability-cerebellar hypoplasia-spondylo-epiphyseal dysplasia syndrome10
HP:0200013HP:0012031Lipomatous tumor1RPL10 CL E G H613410298ORPHA:435938X-linked microcephaly-growth retardation-prognathism-cryptorchidism syndrome10
HP:0200013HP:0012031Lipomatous tumor1SDHB CL E G H639010681ORPHA:201Cowden syndrome237
HP:0200013HP:0012031Lipomatous tumor1SDHC CL E G H639110682ORPHA:201Cowden syndrome147
HP:0200013HP:0012031Lipomatous tumor1SDHD CL E G H639210683ORPHA:201Cowden syndrome129
HP:0200013HP:0012031Lipomatous tumor1SEC23B CL E G H1048310702ORPHA:201Cowden syndrome60
HP:0200013HP:0012031Lipomatous tumor1SPRED1 CL E G H16174220249OMIM:611431Legius syndrome136
HP:0200013HP:0012031Lipomatous tumor1SPRED1 CL E G H16174220249ORPHA:137605Legius syndrome136
HP:0200013HP:0012031Lipomatous tumor1TAF1 CL E G H687211535ORPHA:480907X-linked intellectual disability-global development delay-facial dysmorphism-sacral caudal remnant syndrome21
HP:0200013HP:0012031Lipomatous tumor1TBXT CL E G H686211515OMIM:182940Neural tube defects, susceptibility to
HP:0200013HP:0012031Lipomatous tumor1TRNF CL E G H45587481ORPHA:551MERRF
HP:0200013HP:0012031Lipomatous tumor1TRNH CL E G H45647487ORPHA:551MERRF
HP:0200013HP:0012031Lipomatous tumor1TRNK CL E G H45667489ORPHA:551MERRF
HP:0200013HP:0012031Lipomatous tumor1TRNK CL E G H45667489ORPHA:1349Mitochondrial DNA-related cardiomyopathy and hearing loss
HP:0200013HP:0012031Lipomatous tumor1TRNL1 CL E G H45677490ORPHA:551MERRF
HP:0200013HP:0012031Lipomatous tumor1TRNP CL E G H45717494ORPHA:551MERRF
HP:0200013HP:0012031Lipomatous tumor1TRNQ CL E G H45727495ORPHA:551MERRF
HP:0200013HP:0012031Lipomatous tumor1TRNS1 CL E G H45747497ORPHA:551MERRF
HP:0200013HP:0012031Lipomatous tumor1TRNS2 CL E G H45757498ORPHA:551MERRF
HP:0200013HP:0012031Lipomatous tumor1USF3 CL E G H20571730494ORPHA:201Cowden syndrome1
HP:0200013HP:0012031Lipomatous tumor1VANGL1 CL E G H8183915512OMIM:182940Neural tube defects, susceptibility to111
HP:0200013HP:0012031Lipomatous tumor1VANGL1 CL E G H8183915512OMIM:600145Sacral defect with anterior meningocele111
HP:0200013HP:0012031Lipomatous tumor1VANGL2 CL E G H5721615511OMIM:182940Neural tube defects, susceptibility to2
HP:0200013HP:0012031Lipomatous tumor1ZSWIM6 CL E G H5768829316OMIM:603671Acromelic frontonasal dysostosis5
HP:0200013HP:0012031Lipomatous tumor1ZSWIM6 CL E G H5768829316ORPHA:1827Acromelic frontonasal dysplasia5
HP:0200013HP:0012034Liposarcoma2 CL E G H
HP:0200013HP:0001012Multiple lipomas2ABCC6 CL E G H36857ORPHA:758Pseudoxanthoma elasticumHP:0040283 - Occasional415
HP:0200013HP:0012032Lipoma2AKT1 CL E G H207391ORPHA:201Cowden syndromeHP:0040282 - Frequent54
HP:0200013HP:0001012Multiple lipomas2AKT1 CL E G H207391OMIM:615109Cowden syndrome 654
HP:0200013HP:0012032Lipoma2AKT1 CL E G H207391ORPHA:744Proteus syndromeHP:0040281 - Very frequent54
HP:0200013HP:0001012Multiple lipomas2AKT1 CL E G H207391OMIM:176920Proteus syndrome, somatic.54
HP:0200013HP:0012032Lipoma2AKT1 CL E G H207391OMIM:176920Proteus syndrome, somatic.54
HP:0200013HP:0001012Multiple lipomas2ALX1 CL E G H80921494ORPHA:306542Frontonasal dysplasia-severe microphthalmia-severe facial clefting syndrome5
HP:0200013HP:0001012Multiple lipomas2ALX3 CL E G H257449OMIM:136760Frontonasal dysplasia 19
HP:0200013HP:0012032Lipoma2ALX3 CL E G H257449OMIM:136760Frontonasal dysplasia 19
HP:0200013HP:0001012Multiple lipomas2ALX3 CL E G H257449ORPHA:391474Frontorhiny9
HP:0200013HP:0001012Multiple lipomas2AP2S1 CL E G H1175565OMIM:600740Hypocalciuric hypercalcemia, familial, type III.6
HP:0200013HP:0001012Multiple lipomas2APC CL E G H324583OMIM:175100Adenomatous polyposis coli.3179
HP:0200013HP:0012032Lipoma2APC CL E G H324583ORPHA:247806APC-related attenuated familial adenomatous polyposisHP:0040284 - Very rare3179
HP:0200013HP:0012032Lipoma2APC CL E G H324583ORPHA:79665Gardner syndromeHP:0040282 - Frequent3179
HP:0200013HP:0001012Multiple lipomas2BMPR1A CL E G H6571076ORPHA:79076Juvenile polyposis of infancy385
HP:0200013HP:0012032Lipoma2CCL2 CL E G H634710618OMIM:182940Neural tube defects, susceptibility to.3
HP:0200013HP:0001012Multiple lipomas2CCL2 CL E G H634710618OMIM:182940Neural tube defects, susceptibility to.3
HP:0200013HP:0012032Lipoma2CDC73 CL E G H7957716783ORPHA:99880Hyperparathyroidism-jaw tumor syndromeHP:0040284 - Very rare169
HP:0200013HP:0012032Lipoma2CDC73 CL E G H7957716783ORPHA:143Parathyroid carcinomaHP:0040284 - Very rare169
HP:0200013HP:0001012Multiple lipomas2CDKN1A CL E G H10261784ORPHA:652Multiple endocrine neoplasia type 1HP:0040282 - Frequent2
HP:0200013HP:0001012Multiple lipomas2CDKN1B CL E G H10271785ORPHA:652Multiple endocrine neoplasia type 1HP:0040282 - Frequent102
HP:0200013HP:0001012Multiple lipomas2CDKN1B CL E G H10271785ORPHA:276152Multiple endocrine neoplasia type 4102
HP:0200013HP:0001012Multiple lipomas2CDKN2B CL E G H10301788ORPHA:652Multiple endocrine neoplasia type 1HP:0040282 - Frequent1
HP:0200013HP:0001012Multiple lipomas2CDKN2C CL E G H10311789ORPHA:652Multiple endocrine neoplasia type 1HP:0040282 - Frequent
HP:0200013HP:0001012Multiple lipomas2ENPP1 CL E G H51673356ORPHA:758Pseudoxanthoma elasticumHP:0040283 - Occasional151
HP:0200013HP:0001012Multiple lipomas2FGFR1 CL E G H22603688ORPHA:2396Encephalocraniocutaneous lipomatosisHP:0040281 - Very frequent172
HP:0200013HP:0012032Lipoma2FGFR1 CL E G H22603688OMIM:613001Encephalocraniocutaneous lipomatosis.172
HP:0200013HP:0001012Multiple lipomas2FGFR1 CL E G H22603688OMIM:613001Encephalocraniocutaneous lipomatosis172
HP:0200013HP:0001012Multiple lipomas2FLCN CL E G H20116327310ORPHA:122Birt-Hogg-Dubé syndromeHP:0040282 - Frequent332
HP:0200013HP:0001012Multiple lipomas2FLCN CL E G H20116327310OMIM:135150Birt-Hogg-Dube syndrome332
HP:0200013HP:0001012Multiple lipomas2FUZ CL E G H8019926219OMIM:182940Neural tube defects, susceptibility to.3
HP:0200013HP:0012032Lipoma2FUZ CL E G H8019926219OMIM:182940Neural tube defects, susceptibility to.3
HP:0200013HP:0001012Multiple lipomas2GNA11 CL E G H27674379OMIM:145981Hypocalciuric hypercalcemia, familial, type II.16
HP:0200013HP:0012032Lipoma2KLLN CL E G H10014474837212ORPHA:201Cowden syndromeHP:0040282 - Frequent1
HP:0200013HP:0001012Multiple lipomas2KRAS CL E G H38456407ORPHA:2396Encephalocraniocutaneous lipomatosisHP:0040281 - Very frequent196
HP:0200013HP:0001012Multiple lipomas2LEMD3 CL E G H2359228887ORPHA:1879Melorheostosis with osteopoikilosisHP:0040283 - Occasional68
HP:0200013HP:0001012Multiple lipomas2MEN1 CL E G H42217010OMIM:131100Multiple endocrine neoplasia 1462
HP:0200013HP:0001012Multiple lipomas2MEN1 CL E G H42217010ORPHA:652Multiple endocrine neoplasia type 1HP:0040282 - Frequent462
HP:0200013HP:0001012Multiple lipomas2MFN2 CL E G H992716877ORPHA:2398Multiple symmetric lipomatosisHP:0040281 - Very frequent203
HP:0200013HP:0012032Lipoma2MSTO1 CL E G H5515429678ORPHA:502423Mitochondrial myopathy-cerebellar ataxia-pigmentary retinopathy syndromeHP:0040282 - Frequent
HP:0200013HP:0001012Multiple lipomas2MSTO1 CL E G H5515429678OMIM:617675Myopathy, mitochondrial, and ataxia.
HP:0200013HP:0001012Multiple lipomas2ND5 CL E G H45407461ORPHA:551MERRFHP:0040282 - Frequent
HP:0200013HP:0012032Lipoma2PIK3CA CL E G H52908975OMIM:612918Congenital lipomatous overgrowth, vascular malformations, and epidermal neviHP:0040282 - Frequent162
HP:0200013HP:0012032Lipoma2PIK3CA CL E G H52908975ORPHA:201Cowden syndromeHP:0040282 - Frequent162
HP:0200013HP:0001012Multiple lipomas2PIK3CA CL E G H52908975OMIM:615108Cowden syndrome 5162
HP:0200013HP:0001012Multiple lipomas2PIK3CA CL E G H52908975ORPHA:276280Hemihyperplasia-multiple lipomatosis syndromeHP:0040283 - Occasional162
HP:0200013HP:0012032Lipoma2PTEN CL E G H57289588ORPHA:109Bannayan-Riley-Ruvalcaba syndromeHP:0040281 - Very frequent948
HP:0200013HP:0012032Lipoma2PTEN CL E G H57289588ORPHA:201Cowden syndromeHP:0040282 - Frequent948
HP:0200013HP:0001012Multiple lipomas2PTEN CL E G H57289588OMIM:158350Cowden syndrome 1948
HP:0200013HP:0001012Multiple lipomas2PTEN CL E G H57289588ORPHA:79076Juvenile polyposis of infancy948
HP:0200013HP:0012032Lipoma2PTEN CL E G H57289588ORPHA:744Proteus syndromeHP:0040281 - Very frequent948
HP:0200013HP:0001012Multiple lipomas2PTEN CL E G H57289588ORPHA:2969Proteus-like syndrome948
HP:0200013HP:0001012Multiple lipomas2RNR1 CL E G H45497470ORPHA:551MERRFHP:0040282 - Frequent
HP:0200013HP:0012032Lipoma2RPL10 CL E G H613410298ORPHA:459070X-linked intellectual disability-cerebellar hypoplasia-spondylo-epiphyseal dysplasia syndromeHP:0040283 - Occasional10
HP:0200013HP:0012032Lipoma2RPL10 CL E G H613410298ORPHA:435938X-linked microcephaly-growth retardation-prognathism-cryptorchidism syndrome10
HP:0200013HP:0012032Lipoma2SDHB CL E G H639010681ORPHA:201Cowden syndromeHP:0040282 - Frequent237
HP:0200013HP:0012032Lipoma2SDHC CL E G H639110682ORPHA:201Cowden syndromeHP:0040282 - Frequent147
HP:0200013HP:0012032Lipoma2SDHD CL E G H639210683ORPHA:201Cowden syndromeHP:0040282 - Frequent129
HP:0200013HP:0012032Lipoma2SEC23B CL E G H1048310702ORPHA:201Cowden syndromeHP:0040282 - Frequent60
HP:0200013HP:0001012Multiple lipomas2SPRED1 CL E G H16174220249ORPHA:137605Legius syndrome136
HP:0200013HP:0001012Multiple lipomas2SPRED1 CL E G H16174220249OMIM:611431Legius syndrome.136
HP:0200013HP:0012032Lipoma2TAF1 CL E G H687211535ORPHA:480907X-linked intellectual disability-global development delay-facial dysmorphism-sacral caudal remnant syndromeHP:0040283 - Occasional21
HP:0200013HP:0001012Multiple lipomas2TBXT CL E G H686211515OMIM:182940Neural tube defects, susceptibility to.
HP:0200013HP:0012032Lipoma2TBXT CL E G H686211515OMIM:182940Neural tube defects, susceptibility to.
HP:0200013HP:0001012Multiple lipomas2TRNF CL E G H45587481ORPHA:551MERRFHP:0040282 - Frequent
HP:0200013HP:0001012Multiple lipomas2TRNH CL E G H45647487ORPHA:551MERRFHP:0040282 - Frequent
HP:0200013HP:0001012Multiple lipomas2TRNK CL E G H45667489ORPHA:551MERRFHP:0040282 - Frequent
HP:0200013HP:0001012Multiple lipomas2TRNK CL E G H45667489ORPHA:1349Mitochondrial DNA-related cardiomyopathy and hearing lossHP:0040283 - Occasional
HP:0200013HP:0001012Multiple lipomas2TRNL1 CL E G H45677490ORPHA:551MERRFHP:0040282 - Frequent
HP:0200013HP:0001012Multiple lipomas2TRNP CL E G H45717494ORPHA:551MERRFHP:0040282 - Frequent
HP:0200013HP:0001012Multiple lipomas2TRNQ CL E G H45727495ORPHA:551MERRFHP:0040282 - Frequent
HP:0200013HP:0001012Multiple lipomas2TRNS1 CL E G H45747497ORPHA:551MERRFHP:0040282 - Frequent
HP:0200013HP:0001012Multiple lipomas2TRNS2 CL E G H45757498ORPHA:551MERRFHP:0040282 - Frequent
HP:0200013HP:0012032Lipoma2USF3 CL E G H20571730494ORPHA:201Cowden syndromeHP:0040282 - Frequent1
HP:0200013HP:0001012Multiple lipomas2VANGL1 CL E G H8183915512OMIM:182940Neural tube defects, susceptibility to.111
HP:0200013HP:0012032Lipoma2VANGL1 CL E G H8183915512OMIM:182940Neural tube defects, susceptibility to.111
HP:0200013HP:0012032Lipoma2VANGL1 CL E G H8183915512OMIM:600145Sacral defect with anterior meningocele111
HP:0200013HP:0012032Lipoma2VANGL2 CL E G H5721615511OMIM:182940Neural tube defects, susceptibility to.2
HP:0200013HP:0001012Multiple lipomas2VANGL2 CL E G H5721615511OMIM:182940Neural tube defects, susceptibility to.2
HP:0200013HP:0012032Lipoma2ZSWIM6 CL E G H5768829316OMIM:603671Acromelic frontonasal dysostosis.5
HP:0200013HP:0001012Multiple lipomas2ZSWIM6 CL E G H5768829316ORPHA:1827Acromelic frontonasal dysplasia5
HP:0200013HP:0034009Pelvic lipomatosis3 CL E G H
HP:0200013HP:0030815Lipoma of the tongue3 CL E G H
HP:0200013HP:0025476Testicular lipomatosis3 CL E G H
HP:0200013HP:0012268Myxoid liposarcoma3 CL E G H
HP:0200013HP:0040164Lipomas of eyelids3 CL E G H
HP:0200013HP:0006773Cutaneous angiolipomas3 CL E G H
HP:0200013HP:0001031Subcutaneous lipoma3AKT1 CL E G H207391OMIM:615109Cowden syndrome 6.54
HP:0200013HP:0100251Multiple central nervous system lipomas3ALX1 CL E G H80921494ORPHA:306542Frontonasal dysplasia-severe microphthalmia-severe facial clefting syndrome5
HP:0200013HP:0007541Frontal cutaneous lipoma3ALX3 CL E G H257449OMIM:136760Frontonasal dysplasia 1.9
HP:0200013HP:0100251Multiple central nervous system lipomas3ALX3 CL E G H257449OMIM:136760Frontonasal dysplasia 19
HP:0200013HP:0100251Multiple central nervous system lipomas3ALX3 CL E G H257449ORPHA:391474Frontorhiny9
HP:0200013HP:0001031Subcutaneous lipoma3BMPR1A CL E G H6571076ORPHA:79076Juvenile polyposis of infancyHP:0040284 - Very rare385
HP:0200013HP:0001031Subcutaneous lipoma3CDKN1B CL E G H10271785ORPHA:276152Multiple endocrine neoplasia type 4HP:0040282 - Frequent102
HP:0200013HP:0001031Subcutaneous lipoma3FGFR1 CL E G H22603688OMIM:613001Encephalocraniocutaneous lipomatosis.172
HP:0200013HP:0100251Multiple central nervous system lipomas3FGFR1 CL E G H22603688OMIM:613001Encephalocraniocutaneous lipomatosis.172
HP:0200013HP:0001031Subcutaneous lipoma3MEN1 CL E G H42217010OMIM:131100Multiple endocrine neoplasia 1.462
HP:0200013HP:0001031Subcutaneous lipoma3PIK3CA CL E G H52908975OMIM:615108Cowden syndrome 5.162
HP:0200013HP:0001031Subcutaneous lipoma3PTEN CL E G H57289588OMIM:158350Cowden syndrome 1.948
HP:0200013HP:0001031Subcutaneous lipoma3PTEN CL E G H57289588ORPHA:79076Juvenile polyposis of infancyHP:0040284 - Very rare948
HP:0200013HP:0001031Subcutaneous lipoma3PTEN CL E G H57289588ORPHA:2969Proteus-like syndromeHP:0040281 - Very frequent948
HP:0200013HP:0012033Sacral lipoma3RPL10 CL E G H613410298ORPHA:435938X-linked microcephaly-growth retardation-prognathism-cryptorchidism syndromeHP:0040282 - Frequent10
HP:0200013HP:0012033Sacral lipoma3VANGL1 CL E G H8183915512OMIM:600145Sacral defect with anterior meningocele.111
HP:0200013HP:0100251Multiple central nervous system lipomas3ZSWIM6 CL E G H5768829316ORPHA:1827Acromelic frontonasal dysplasia5
HP:0200013HP:0007596Painful subcutaneous lipomas4 CL E G H
HP:0200013HP:0006866Midline central nervous system lipomas4ALX1 CL E G H80921494ORPHA:306542Frontonasal dysplasia-severe microphthalmia-severe facial clefting syndrome5
HP:0200013HP:0006866Midline central nervous system lipomas4ALX3 CL E G H257449OMIM:136760Frontonasal dysplasia 19
HP:0200013HP:0006866Midline central nervous system lipomas4ALX3 CL E G H257449ORPHA:391474Frontorhiny9
HP:0200013HP:0006866Midline central nervous system lipomas4ZSWIM6 CL E G H5768829316ORPHA:1827Acromelic frontonasal dysplasiaHP:0040281 - Very frequent5
HP:0200013HP:0006931Pericallosal lipoma5ALX1 CL E G H80921494ORPHA:306542Frontonasal dysplasia-severe microphthalmia-severe facial clefting syndromeHP:0040283 - Occasional5
HP:0200013HP:0006931Pericallosal lipoma5ALX3 CL E G H257449OMIM:136760Frontonasal dysplasia 19
HP:0200013HP:0006931Pericallosal lipoma5ALX3 CL E G H257449ORPHA:391474FrontorhinyHP:0040282 - Frequent9
HP:0200013HP:0034014Tubulonodular pericallosal lipoma6 CL E G H
HP:0200013HP:0034013Curvilinear pericallosal lipoma6 CL E G H


Genes (48) :ABCC6 AKT1 ALX1 ALX3 AP2S1 APC BMPR1A CCL2 CDC73 CDKN1A CDKN1B CDKN2B CDKN2C ENPP1 FGFR1 FLCN FUZ GNA11 KLLN KRAS LEMD3 MEN1 MFN2 MSTO1 ND5 PIK3CA PTEN RNR1 RPL10 SDHB SDHC SDHD SEC23B SPRED1 TAF1 TBXT TRNF TRNH TRNK TRNL1 TRNP TRNQ TRNS1 TRNS2 USF3 VANGL1 VANGL2 ZSWIM6

Diseases (44) :ORPHA:758 ORPHA:201 OMIM:615109 ORPHA:744 OMIM:176920 ORPHA:306542 OMIM:136760 ORPHA:391474 OMIM:600740 OMIM:175100 ORPHA:247806 ORPHA:79665 ORPHA:79076 OMIM:182940 ORPHA:99880 ORPHA:143 ORPHA:652 ORPHA:276152 ORPHA:2396 OMIM:613001 ORPHA:122 OMIM:135150 OMIM:145981 ORPHA:1879 OMIM:131100 ORPHA:2398 ORPHA:502423 OMIM:617675 ORPHA:551 OMIM:612918 OMIM:615108 ORPHA:276280 ORPHA:109 OMIM:158350 ORPHA:2969 ORPHA:459070 ORPHA:435938 OMIM:611431 ORPHA:137605 ORPHA:480907 ORPHA:1349 OMIM:600145 OMIM:603671 ORPHA:1827
 

Human Phenotype Ontology(HPO) is developed by the Human Phenotype Ontology Consortium. The version used here is December 15 2022 release.